PAB 0.00% 0.6¢ patrys limited

Ann: Appendix 4C - Quarterly - 31 March 2023, page-2

  1. 9,194 Posts.
    lightbulb Created with Sketch. 2362
    ".....we were delighted to report positive preclinical data on the ability of PAT-DX3 to be used for synthetic lethality strategies which, along with its potential for the delivery of therapeutic payloads into the cell and cell nucleus, remains an area of high interest with potential partners.”
 
watchlist Created with Sketch. Add PAB (ASX) to my watchlist
(20min delay)
Last
0.6¢
Change
0.000(0.00%)
Mkt cap ! $12.34M
Open High Low Value Volume
0.6¢ 0.6¢ 0.6¢ $429 71.43K

Buyers (Bids)

No. Vol. Price($)
6 2134480 0.6¢
 

Sellers (Offers)

Price($) Vol. No.
0.7¢ 1128726 3
View Market Depth
Last trade - 12.08pm 03/09/2024 (20 minute delay) ?
PAB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.